| |
| |
|
| Insider
Information: |
Dorling Janet |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
284,738 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,118 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
284,738 |
|
|
| Total
Value |
$7,118 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Achaogen Inc |
AKAO |
Chief Commercial Officer |
2019-02-21 |
284,738 |
2018-06-26 |
0 |
Premium* |
|
|
Cymabay Therapeutics, Inc. |
CBAY |
Director |
2024-02-12 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2024-02-12 |
4 |
AS |
$31.97 |
$191,849 |
D/D |
(6,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2024-02-12 |
4 |
OE |
$4.63 |
$27,780 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2024-01-10 |
4 |
AS |
$23.86 |
$143,144 |
D/D |
(6,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2024-01-10 |
4 |
OE |
$4.63 |
$27,780 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2023-12-11 |
4 |
AS |
$20.07 |
$120,422 |
D/D |
(6,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2023-12-11 |
4 |
OE |
$4.63 |
$27,780 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2023-11-10 |
4 |
AS |
$15.24 |
$106,700 |
D/D |
(7,000) |
0 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Director |
– • – |
2023-11-10 |
4 |
OE |
$4.63 |
$32,410 |
D/D |
7,000 |
7,000 |
0 |
- |
|
| AKAO |
Achaogen Inc |
Chief Commercial Officer |
• – – |
2019-02-21 |
4 |
S |
$0.89 |
$946 |
D/D |
(1,063) |
284,738 |
0 |
- |
|
| AKAO |
Achaogen Inc |
Chief Commercial Officer |
• – – |
2019-02-05 |
4 |
S |
$1.35 |
$1,104 |
D/D |
(818) |
285,801 |
0 |
- |
|
| AKAO |
Achaogen Inc |
Chief Commercial Officer |
• – – |
2019-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
187,800 |
286,619 |
0 |
- |
|
| AKAO |
Achaogen Inc |
Chief Commercial Officer |
• – – |
2018-06-26 |
4 |
S |
$9.59 |
$4,316 |
D/D |
(450) |
23,819 |
0 |
- |
|
| AKAO |
Achaogen Inc |
Chief Commercial Officer |
• – – |
2018-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,300 |
24,269 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
